VYNE Therapeutics Inc. | OpenBizGraph

Company name

VYNE Therapeutics Inc.

Website

Start date

2003-01-01

End date

Ticker

Listed market

NASDAQ

Country

United States of America

Business activities

Clinical-stage biopharmaceutical company

BET inhibitor drug candidates for immuno-inflammatory diseases

Head office

P.O. BOX 125 Stewartsville, New Jersey 08886 United States

Chief executive

David Domzalski

Employees (non-consolidated)

10 people

Employees (consolidated)

Related companies

Company name

Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

Relationship graph

News

+ Loaded when opened

Data sources

News pages

Own domain

✅

Last updated

2026-09-21 18:15 (Model: )